Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa

Molecular Vision

Volumn 19, Issue , 2013, Pages 1453-1470

  Pelikan, Zdenek ^a  

^a Allergy Research Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE E4; MYELOPEROXIDASE; TRYPTASE;

ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MALE; NOSE ALLERGY; NOSE MUCOSA; PRIORITY JOURNAL; PROVOCATION TEST;

ADULT; ALLERGENS; CASE-CONTROL STUDIES; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; FEMALE; HUMANS; MALE; NASAL MUCOSA; NASAL PROVOCATION TESTS; TEARS; YOUNG ADULT;

EID: 84880293768     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Bielory L, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am 2008; 28:43-58. [PMID: 18282545].
2. Barney NP, Graziano FM, Cook EB, Stahl JL. Allergic and immunologic diseases of the eye. In: Adkinson NF, Bochner BS, JW, Busse WW, Holgate ST, Lemanske RF, Simons FE, eds. Middleton's Allergy, principles & practice (7th Ed). Philadelphia: Mosby-Elsevier Inc 2009: 1117-1137.
3. nd Ed. Oxford: Willey Blackwell Publ Ltd, 2008; 1482-1509.
4. Bielory L. Allergic and immunologic disorders of the eye; Part I: Immunology of the eye; Part II: Ocular allergy. J Allergy Clin Immunol 2000; 106:805-16., 1019-32. [PMID: 11080700].
5. Pelikan Z. The causal role of the nasal allergy in some patients with allergic conjunctivitis. Allergy 2002; 57:Suppl 732-30.
6. Pelikan Z. Late nasal response-its clinical characteristics, features, and possible mechanisms. In: Dorsch W (Ed). Late Phase Allergic Reactions. Boca Raton, Ann Arbor, Boston (USA): CRC Press 1990: 111-155.
7. Pelikan Z. The late nasal response. Thesis. Amsterdam: The Free University of Amsterdam 1996.
8. Pelikan Z. Seasonal and perennial allergic conjunctivitis: the possible role of nasal allergy. Clin Experiment Ophthalmol 2009; 37:448-57. [PMID: 19624340].
9. Pelikan Z. The possible involvement of nasal allergy in allergic keratoconjunctivitis. Eye (Lond) 2009; 23:1653-60. [PMID: 19011606].
10. Pelikan Z. Allergic conjunctivitis and nasal allergy. Curr Allergy Asthma Rep 2010; 10:295-302. [PMID: 20431970].
11. Bacon AS, Ahluwalia P, Irani AM, Schwartz LB, Holgate ST, Church MK, McGill JI. Tear and conjunctival changes during the allergen-induced early- and late-phase responses. J Allergy Clin Immunol 2000; 106:948-54. [PMID: 11080719].
12. Leonardi A, Fregona IA, Plebani M, Secchi AG, Calder VL. Th1- and Th2-type cytokines in chronic ocular allergy. Graefes Arch Clin Exp Ophthalmol 2006; 244:1240-5. [PMID: 16538446].
13. Leonardi A, Curnow SJ, Zhan H, Calder VL. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy 2006; 36:777-84. [PMID: 16776679].
14. Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997; 100:817-24. [PMID: 9438492].
15. Bonini S, Bonini S, Berruto A, Tomassini M, Carlesimo S, Bucci MG, Balsano F. Conjunctival provocation test as a model for the study of allergy and inflammation in humans. Int Arch Allergy Appl Immunol 1989; 88:144-8. [PMID: 2651314].
16. Leonardi A, De Dominics C, Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol 2007; 7:429-35. [PMID: 17873584].
17. Anderson DF. The conjunctival late-phase reaction and allergen provocation in the eye. Clin Exp Allergy 1996; 26:1105-7. [PMID: 8911693].
18. Leonardi A. In-vivo diagnostic measurements of ocular inflammation. Curr Opin Allergy Clin Immunol 2005; 5:464-72. [PMID: 16131925].
19. Choi SH, Bielory L. Late-phase reaction in ocular allergy. Curr Opin Allergy Clin Immunol 2008; 8:438-44. [PMID: 18769198].
20. Dua HS, Gomes JA, Donoso LA, Laibson PR. The ocular surface as part of the mucosal immune system: conjunctival mucosa-specific lymphocytes in ocular surface pathology. Eye (Lond) 1995; 9:261-7. [PMID: 7556729].
21. Cook EB. Tear cytokines in acute and chronic ocular allergic inflammation. Curr Opin Allergy Clin Immunol 2004; 4:441-5. [PMID: 15349046].
22. Friedlaender MH. Conjunctival provocation testing: Overview of recent clinical trials in ocular allergy. Int Ophthalmol Clin 2003; 43:95-104. [PMID: 12544398].
23. Pelikan Z. Cytologic changes in tears during the late type of secondary conjunctival response induced by nasal allergy. In: Pelikan Z (Ed). Conjunctivitis-A complex and multifaceted disorder. Rijeka (Croatia): InTech 2011; 75-92-15.
24. Melillo G, Bonini S, Cocco G, Davies RJ, De Monchy JGR, Frølund L, Pelikan Z. Provocation tests with allergens. Allergy 1997; 52:Suppl 5-44. [PMID: 9254578].
25. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 1990; 108:84-8. [PMID: 2297337].
26. Abelson M, Howes J, George M. The conjunctival provocation test model of ocular allergy: Utility for assessment of an ocular corticosteroid, Loteprednol etabonate. J Ocul Pharmacol Ther 1998; 14:533-42. [PMID: 9867336].
27. Abelson MB, George MA, Schaefer K, Smith LM. Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine in the clinical allergen challenge model of allergic conjunctivitis. J Allergy Clin Immunol 1994; 94:458-64. [PMID: 7916020].
28. rd Ed. Washington (DC): American Society of Microbiology 1986; 675-684.
29. Pelikan Z, Pelikan-Filipek M. Cytologic changes in the nasal secretions during the immediate nasal response. J Allergy Clin Immunol 1988; 82:1103-12. [PMID: 3204254].
30. Pelikan Z, Pelikan-Filipek M. Cytologic changes in the nasal secretion during the late nasal response. J Allergy Clin Immunol 1989; 83:1068-79. [PMID: 2732407].
31. O'Sullivan NL, Montgomery PC, Sullivan DA. Ocular mucosal immunity. In: Mestecky J, Binnenstock J, Lamm M, Strober W, McGhee J, Mayer L (eds). Mucosal immunology (3rd Ed). Burlington (MA,USA), San Diego (CA,USA), London: Elsevier-Academic Press 2005: 1477-1496.
32. Youngman KR, Lazarus NH, Butcher EC. Lymphocyte homing: Chemokines and adhesion molecules in T cell and IgA plasma cell localization in the mucosal immune system. In: Mestecky J, Binnenstock J, Lamm M, Strober W, McGhee J, Mayer L (eds). Mucosal immunology (3rd). Burlington (MA,USA), San Diego (CA,USA), London:Elsevier-Academic Press 2005: 667-680.
33. Sacchetti M, Micera A, Lambiase A, Speranza S, Mantelli F, Petrachi G, Bonini S, Bonini S. Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. Mol Vis 2011; 17:47-52. [PMID: 21245958].
34. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res 2006; 82:885-98. [PMID: 16309672].
35. Leonardi A, Borghesan F, Faggian D, DePaoli M, Secchi AG, Plebani M. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol 2000; 129:151-8. [PMID: 10682966].
36. Montan PG., Hage-Hamsteren van M, Zetterström O. Sustained eosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge. Clin Exp Allergy 1996; 26:1125-30. [PMID: 8911697].
37. Tabbara KF. Tear tryptase in vernal keratoconjunctivitis. Arch Ophthalmol 2001; 119:338-42. [PMID: 11231766].
38. Leonardi A, Busato F, Fregona I, Plebani M, Secchi AG. Anti-inflammatory and antiallergic effects of ketorolac trimethamine in the conjunctival provocation model. Br J Ophthalmol 2000; 84:1228-32. [PMID: 11049945].
39. Mita H, Sakuma Y, Shida T, Akiyama K. Release of chemical mediators in the conjunctival lavage fluids after eye provocation with allergen or compound 48/80. Arerugi 1994; 43:800-8. [PMID: 7526828].
40. Kari O, Salo OP, Halmepuro L, Suvilehto K. Tear histamine during allergic conjunctivitis challenge. Graefes Arch Clin Exp Ophthalmol 1985; 223:60-2. [PMID: 2408967].
41. Helintö M, Renkonen R, Tervo T, Vesaluoma M. Saaren-Seppälä, Haahtela T, Kirveskari J. Direct in vivo monitoring of acute allergic reactions in human conjunctiva. J Immunol 2004; 172:3235-42. [PMID: 14978131].
42. Oh JW, Shin JC, Jang SJ, Lee HB. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum of children with allergic conjunctivitis. Ann Allergy Asthma Immunol 1999; 82:579-85. [PMID: 10400487].
43. Nathan H, Naveh N, Meyer E. Levels of prostaglandin E2 and leukotriene B4 in tears of vernal conjunctivitis patients during a therapeutical trial with indomethacin. Doc Ophthalmol 1994; 85:247-57. [PMID: 7924852].
44. Bisgaard H, Ford-Hutchinson AW, Charleson S, Taudorf E. Production of leukotrienes in human skin and conjunctival mucosa after specific allergen challenge. Allergy 1985; 40:417-23. [PMID: 2996379].
45. Leonardi AA, Smith LM, Fregona IA, Salmaso M, Secchi AG. Tear histamine and histaminase during the early (EPR) and late-16-(LPR) phases of the allergic reaction and the effects of lodoxamide. Eur J Ophthalmol 1996; 6:106-12. [PMID: 8823580].
46. Leonardi A, Sathe S, Bartolotti M, Beaton A, Sack R. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy 2009; 64:710-7. [PMID: 19220217].
47. Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferongamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 2000; 30:103-9. [PMID: 10606937].
48. Sack RA, Conradi L, Krumholz D, Beaton A, Sathe S, Morris C. Membrane array characterization of 80 chemokines, cytokines, and growth factors in openand closed-eye tears: angiogenin and other defense system constituents. Invest Ophthalmol Vis Sci 2005; 46:1228-38. [PMID: 15790883].
49. Leonardi A, Borghesan F, Faggian D, Secchi A, Plebani M. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995; 50:610-3. [PMID: 8588697].
50. Bonini S, Lambiase A, Sacchetti M, Bonini S. Cytokines in ocular allergy. Int Ophthalmol Clin 2003; 43:27-32. [PMID: 12544392].
51. Calder VL, Jolly G, Hingorani M, Adamson P, Leonardi A, Secchi AG, Buckley RJ, Lighman S. Cytokine production and mRNA expression by conjuctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy 1999; 29:1214-22. [PMID: 10469030].
52. Ahluwalia P, Anderson DF, Wilson SJ, McGill JI, Church MK. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. J Allergy Clin Immunol 2001; 108:449-54. [PMID: 11544467].
53. Magrini L, Bonini S, Centofanti M, Schiavone M, Bonini S. Tear tryptase levels and allergic conjunctivitis. Allergy 1996; 51:577-81. [PMID: 8874662].
54. Proud D, Sweet J, Stein P, Settipane RA, Kagey-Sobotka A, Friedlaender MH, Lichtenstein LM. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 1990; 85:896-905. [PMID: 1692049].
55. Friedlaender MH. Conjunctival provocative tests: A model of human ocular allergy. Trans Am Ophthalmol Soc 1989; 87:577-97. [PMID: 2562530].
56. Pelikan Z. Cytologic changes in tears during the secondary conjunctival response induced by nasal allergy. Br J Ophthalmol 2012; 96:941-8. [PMID: 22715090].
57. Ono SJ, Abelson MB. Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 2005; 115:118-22. [PMID: 15637556].
58. Nakamura Y, Sotozono C, Kinoshita S. Inflammatory cytokines in normal human tears. Curr Eye Res 1998; 17:673-6. [PMID: 9663859].
59. Carreño E, Enriquez-de Salamanca A, Teson M, Garcia-Vazquez C, Stern ME, Whitcup SM, Calonge M. Cytokine and chemokine levels in tears from healthy subjects. Acta Ophthalmol (Copenh) 2010; 88:250-8.
60. th Ed. St.Louis, Baltimore, Boston, Chicago, London, Philadelphia, Sydney, Toronto: Mosby-Year Book Inc 1993; 226-242.
61. Pelikan Z, Pelikan M. The role of the nasal mucosa in some cases of allergic conjunctivitis and the effects of disodium cromoglycate (DSCG). J Allergy Clin Immunol 1985; 75:Suppl 1186-.
62. Pelikan Z. Allergic conjunctivitis: primary and secondary role of the allergy reaction in the nose. Dutch Journal of Medicine 1988; 132:561-3.
63. Pelikan Z. Anti-allergic drugs and immunotherapy. In: Principles of Immunopharmacology. Nijkamp FP, Parnham MJ (Eds) Basel, Boston, Berlin: Birkhäuser Verlag, 1999; 243-268.